Cerity Partners’s MaxLinear MXL Stock Holding History

Cerity Partners’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,523	Closed	-$217K	–	2974
2025 Q3	$217K	Buy	13,523 +2,224	+20%	+$34.9K	﹤0.01%	2461
2025 Q2	$161K	Buy	+11,299	New	+$130K	﹤0.01%	2405

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Cerity Partners's MXL Position: Q4 2025 in Review

Cerity Partners sold out of MaxLinear (MXL) in Q4 2025, closing a stake of 13,523 shares — an estimated $217K sold.

Cerity Partners first reported a position in MXL in Q2 2025 and held it in 2 quarters. The position peaked at $217K in Q3 2025. 240 funds tracked by Wall St. Rank hold MXL as of Q4 2025.

Cerity Partners reported no remaining MaxLinear position as of Q4 2025 after selling out during the quarter.
Cerity Partners sold 13,523 MaxLinear shares in Q4 2025, an estimated $217K.
Cerity Partners first reported a position in MaxLinear in Q2 2025 and held it in 2 quarters.
Cerity Partners's MaxLinear position peaked at $217K in Q3 2025.
240 funds tracked by Wall St. Rank held MaxLinear as of Q4 2025.

Based on Cerity Partners's 13F filing for Q4 2025, filed 11 Feb 2026.